Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 2
2008 2
2010 4
2011 1
2012 2
2013 3
2014 4
2015 4
2016 5
2017 3
2018 6
2019 7
2020 6
2021 14
2022 14
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Dermoscopy as a Tool for Identifying Potentially Metastatic Thin Melanoma: A Clinical-Dermoscopic and Histopathological Case-Control Study.
De Giorgi V, Silvestri F, Cecchi G, Venturi F, Zuccaro B, Perillo G, Cosso F, Maio V, Simi S, Antonini P, Pillozzi S, Antonuzzo L, Massi D, Doni L. De Giorgi V, et al. Among authors: pillozzi s. Cancers (Basel). 2024 Apr 1;16(7):1394. doi: 10.3390/cancers16071394. Cancers (Basel). 2024. PMID: 38611072 Free PMC article.
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients.
Lavacchi D, Polvani S, Taddei A, Scolari F, Messerini L, Caliman E, Moraldi L, Guidolin A, Grazi GL, Galli A, Pillozzi S, Antonuzzo L. Lavacchi D, et al. Among authors: pillozzi s. Front Oncol. 2023 Dec 5;13:1295936. doi: 10.3389/fonc.2023.1295936. eCollection 2023. Front Oncol. 2023. PMID: 38130990 Free PMC article.
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients.
Lavacchi D, Gelmini S, Calabri A, Rossi G, Simi L, Caliman E, Mancini I, Salvianti F, Petroni G, Guidolin A, Scolari F, Messerini L, Pillozzi S, Pinzani P, Antonuzzo L. Lavacchi D, et al. Among authors: pillozzi s. Heliyon. 2023 Nov 4;9(11):e21853. doi: 10.1016/j.heliyon.2023.e21853. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027900 Free PMC article.
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival.
Gambale E, Palmieri VE, Rossi V, Francini E, Bonato A, Salfi A, Galli L, Mela MM, Pillozzi S, Antonuzzo L. Gambale E, et al. Among authors: pillozzi s. Cancer Diagn Progn. 2023 Sep 3;3(5):538-542. doi: 10.21873/cdp.10252. eCollection 2023 Sep-Oct. Cancer Diagn Progn. 2023. PMID: 37671314 Free PMC article.
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer.
Lavacchi D, Roviello G, Guidolin A, Romano S, Venturini J, Caliman E, Vannini A, Giommoni E, Pellegrini E, Brugia M, Pillozzi S, Antonuzzo L. Lavacchi D, et al. Among authors: pillozzi s. Int J Mol Sci. 2023 Mar 19;24(6):5840. doi: 10.3390/ijms24065840. Int J Mol Sci. 2023. PMID: 36982913 Free PMC article. Review.
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.
Lavacchi D, Fancelli S, Buttitta E, Vannini G, Guidolin A, Winchler C, Caliman E, Vannini A, Giommoni E, Brugia M, Cianchi F, Pillozzi S, Roviello G, Antonuzzo L. Lavacchi D, et al. Among authors: pillozzi s. Int J Mol Sci. 2023 Mar 2;24(5):4877. doi: 10.3390/ijms24054877. Int J Mol Sci. 2023. PMID: 36902306 Free PMC article. Review.
85 results